ArticleInternational journal of surgery case reports2025
Mantle cell diffuse large B-cell lymphoma revealed by lower urinary tract symptoms: A case report and literature review.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Population-Based analysis of conditional survival patterns and dynamic prognostic modeling in primary urinary tract lymphoma.Annals of hematology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMantle cell lymphoma with diffuse large B cell lymphoma transformation (MCL-DLBCL) is a rare and aggressive form of lymphoma that typically presents with non-specific symptoms. It is uncommon for this lymphoma to manifest as lower urinary tract symptoms (LUTS), such as dysuria, hematuria, and pelvic pain, often leading to misdiagnosis and delayed treatment. CASE PRESENTATION: We present the case of a 62-year-old male patient who presented with irritative urinary symptoms. After a series of diagnostic tests, including imaging (MRI, PET-CT) and histopathological analysis, the final diagnosis was mantle cell lymphoma (MCL) with transformation into mantle cell diffuse large B-cell lymphoma (MCL-DLBCL) involving the prostate, lymph nodes, and stomach. Prostate biopsy and immunohistochemical analysis confirmed this diagnosis. DISCUSSION: This case highlights the rare presentation of MCL-DLBCL with urinary symptoms. The role of advanced imaging techniques, such as MRI and PET-CT, in identifying the involved organs is emphasized. The study also underscores the importance of prostate biopsy and immunohistochemical analysis to confirm the diagnosis and distinguish between MCL transformation into MCL-DLBCL or a composite lymphoma. A multidisciplinary approach is crucial for early detection and proper management.
conclusionThe patient received a combination of chemotherapy, including rituximab and other agents, leading to complete remission. After chemotherapy, the patient underwent autologous hematopoietic stem cell transplantation, contributing to his recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.